Enanta Pharmaceuticals (ENTA) Other Working Capital Changes (2016 - 2025)
Enanta Pharmaceuticals filings provide 14 years of Other Working Capital Changes readings, the most recent being -$834000.0 for Q4 2025.
- On a quarterly basis, Other Working Capital Changes fell 157.72% to -$834000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.2 million, a 288.91% decrease, with the full-year FY2025 number at $379000.0, up 144.59% from a year prior.
- Other Working Capital Changes hit -$834000.0 in Q4 2025 for Enanta Pharmaceuticals, up from -$1.4 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $3.8 million in Q2 2023 to a low of -$7.3 million in Q1 2021.
- Median Other Working Capital Changes over the past 5 years was -$624000.0 (2024), compared with a mean of -$883150.0.
- The widest YoY moves for Other Working Capital Changes: up 8127.78% in 2024, down 2084.54% in 2024.
- Enanta Pharmaceuticals' Other Working Capital Changes stood at -$1.5 million in 2021, then soared by 97.26% to -$40000.0 in 2022, then soared by 55.0% to -$18000.0 in 2023, then surged by 8127.78% to $1.4 million in 2024, then plummeted by 157.72% to -$834000.0 in 2025.
- The last three reported values for Other Working Capital Changes were -$834000.0 (Q4 2025), -$1.4 million (Q3 2025), and $314000.0 (Q2 2025) per Business Quant data.